Hypertension-related gene polymorphisms of G-protein-coupled receptor kinase 4 are associated with NT-proBNP concentration in normotensive healthy adults

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Yatabe, Junichi ^a,b   Yatabe, Midori S ^a   Yoneda, Minoru ^b   Felder, Robin A ^c   Jose, Pedro A ^d   Sanada, Hironobu ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL VETERINARY ASSAY LABORATORY   (Japan)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; G PROTEIN COUPLED RECEPTOR KINASE 4;

ADULT; ARTICLE; AUGMENTATION INDEX; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; JAPANESE; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

EID: 84868288756     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/806810     Document Type: Article

References (37)

1. Jose P. A., Eisner G. M., Felder R. A., Role of dopamine receptors in the kidney in the regulation of blood pressure. Current Opinion in Nephrology and Hypertension 2002 11 1 87 92 2-s2.0-0036142375 10.1097/00041552-200201000-00013 (Pubitemid 34053343)
2. Felder R. A., Sanada H., Xu J., Yu P. Y., Wang Z., Watanabe H., Asico L. D., Wang W., Zheng S., Yamaguchi I., Williams S. M., Gainer J., Brown N. J., Hazen-Martin D., Wong L. J. C., Robillard J. E., Carey R. M., Eisner G. M., Jose P. A., G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proceedings of the National Academy of Sciences of the United States of America 2002 99 6 3872 3877 2-s2.0-0037133693 10.1073/pnas.062694599 (Pubitemid 34252198)
3. Sanada H., Yatabe J., Midorikawa S., Katoh T., Hashimoto S., Watanabe T., Xu J., Luo Y., Wang X., Zeng C., Armando I., Felder R. A., Jose P. A., Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension 2006 47 6 1131 1139 2-s2.0-33744972107 10.1161/01.HYP.0000222004.74872.17 (Pubitemid 44289171)
4. Sanada H., Yatabe J., Midorikawa S., Hashimoto S., Watanabe T., Moore J. H., Ritchie M. D., Williams S. M., Pezzullo J. C., Sasaki M., Eisner G. M., Jose P. A., Felder R. A., Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clinical Chemistry 2006 52 3 352 360 2-s2.0-33644547657 10.1373/clinchem.2005.059139
5. Munshi A., Sharma V., Kaul S., Rajeshwar K., Babu M. S., Shafi G., Anila A. N., Balakrishna N., Alladi S., Jyothy A., Association of the-344 C/T aldosterone synthase (CYP11B2) gene variant with hypertension and stroke. Journal of the Neurological Sciences 2010 296 1-2 34 38 2-s2.0-77956881582 10.1016/j.jns.2010.06.013
6. Masson S., Latini R., Anand I. S., Vago T., Angelici L., Barlera S., Missov E. D., Clerico A., Tognoni G., Cohn J. N., Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clinical Chemistry 2006 52 8 1528 1538 2-s2.0-33746595717 10.1373/clinchem.2006.069575 (Pubitemid 44148316)
7. DeFilippi C. R., Seliger S. L., Maynard S., Christenson R. H., Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clinical Chemistry 2007 53 8 1511 1519 2-s2.0-34547629797 10.1373/clinchem.2006.084533 (Pubitemid 47206349)
8. Luchner A., Hengstenberg C., Löwel H., Riegger G. A. J., Schunkert H., Holmer S., Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 2005 46 1 118 123 2-s2.0-21744443421 10.1161/01.HYP. 0000170140.36633.8f (Pubitemid 40946501)
9. Freel E. M., Ingram M., Wallace A. M., White A., Fraser R., Davies E., Connell J. M. C., Effect of variation in CYP11B1 and CYP11B2 on corticosteroid phenotype and hypothalamic-pituitary-adrenal axis activity in hypertensive and normotensive subjects. Clinical Endocrinology 2008 68 5 700 706 2-s2.0-42149174492 10.1111/j.1365-2265.2007.03116.x (Pubitemid 351533448)
10. Nejatizadeh A., Kumar R., Stobdan T., Goyal A. K., Gupta M., Tyagi S., Jain S. K., Pasha M. A. Q., CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension. Clinical Biochemistry 2010 43 1-2 136 141 2-s2.0-72649101950 10.1016/j.clinbiochem.2009.09.015
11. Modlinger P. S., Wilcox C. S., Aslam S., Nitric oxide, oxidative stress, and progression of chronic renal failure. Seminars in Nephrology 2004 24 4 354 365 2-s2.0-3142574854 10.1016/j.semnephrol.2004.04.007 (Pubitemid 38900635)
12. Ogihara T., Kikuchi K., Matsuoka H., Fujita T., Higaki J., Horiuchi M., Imai Y., Imaizumi T., Ito S., Iwao H., Kario K., Kawano Y., Kim-Mitsuyama S., Kimura G., Matsubara H., Matsuura H., Naruse M., Saito I., Shimada K., Shimamoto K., Suzuki H., Takishita S., Tanahashi N., Tsuchihashi T., Uchiyama M., Ueda S., Ueshima H., Umemura S., Ishimitsu T., Rakugi H., The Japanese society of hypertension guidelines for the management of hypertension (JSH 2009). Hypertension Research 2009 32 1 3 107 2-s2.0-77952304034 10.1038/hr.2008.18
13. Kawamura M., Kusano Y., Takahashi T., Owada M., Sugawara T., Effectiveness of a spot urine method in evaluating daily salt intake in hypertensive patients taking oral antihypertensive drugs. Hypertension Research 2006 29 6 397 402 2-s2.0-33746280851 10.1291/hypres.29.397 (Pubitemid 44102806)
14. Kawasaki T., Ueno M., Uezono K., Average urinary excretion of sodium in 24 hours can be estimated from a spot-urine specimen. Japanese Circulation Journal 1982 46 9 948 953 2-s2.0-0020424156 (Pubitemid 13199555)
15. Liu Y., Qin W., Hou S., Shan G., Zhuo M., Chen Y., Cui C., Caidan L., Qiu C., A-6G variant of the angiotensinogen gene and essential hypertension in Han, Tibetan, and Yi populations. Hypertension Research 2001 24 2 159 163 2-s2.0-0035034854 10.1291/hypres.24.159 (Pubitemid 32377587)
16. Sato M., Soma M., Nakayama T., Kanmatsuse K., Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension 2000 36 2 183 186 2-s2.0-0033883491 (Pubitemid 30626986)
17. Barlassina C., Schork N. J., Manunta P., Citterio L., Sciarrone M. T., Lanella G., Bianchi G., Cusi D., Synergistic effect of α -adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney International 2000 57 3 1083 1090 2-s2.0-0008190467 10.1046/j.1523-1755. 2000.00935.x (Pubitemid 30434797)
18. Lindpaintner K., Pfeffer M. A., Kreutz R., Stampfer M. J., Grodstein F., Lamotte F., Buring J., Hennekens C. H., A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. The New England Journal of Medicine 1995 332 11 706 711 2-s2.0-0028930348 10.1056/NEJM199503163321103
19. Zeng C., van Villar A. M., Eisner G. M., Williams S. M., Felder R. A., Jose P. A., G protein-coupled receptor kinase 4: role in blood pressure regulation. Hypertension 2008 51 6 1449 1455 2-s2.0-45849135591 10.1161/HYPERTENSIONAHA.107.096487
20. Zhu H., Lu Y., Wang X., Treiber F. A., Harshfield G. A., Snieder H., Dong Y., The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins. American Journal of Hypertension 2006 19 1 61 66 2-s2.0-32344446995 10.1016/j.amjhyper.2005.07.007 (Pubitemid 43217035)
21. Weinberger M. H., Salt sensitivity is associated with an increased mortality in both normal and hypertensive humans. Journal of Clinical Hypertension 2002 4 4 274 276 2-s2.0-0036342009
22. Omland T., Sabatine M. S., Jablonski K. A., Rice M. M., Hsia J., Wergeland R., Landaas S., Rouleau J. L., Domanski M. J., Hall C., Pfeffer M. A., Braunwald E., Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease. The PEACE trial. Journal of the American College of Cardiology 2007 50 3 205 214 2-s2.0-33947330983 10.1016/j.jacc.2007.03.038 (Pubitemid 47031568)
23. Kragelund C., Gronning B., Kober L., Hildebrandt P., Steffensen R., N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. The New England Journal of Medicine 2005 352 7 666 675 2-s2.0-13744259846 10.1056/NEJMoa042330 (Pubitemid 40239214)
24. Khouri M. G., Peshock R. M., Ayers C. R., de Lemos J. A., Drazner M. H., A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry the dallas heart study. Circulation: Cardiovascular Imaging 2010 3 2 164 171 2-s2.0-77951884695 10.1161/CIRCIMAGING.109.883652
25. Reny J. L., Millot O., Vanderecamer T., Vergnes C., Barazer I., Sedighian S., Berdagué P., Admission NT-proBNP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspnea. European Journal of Internal Medicine 2009 20 1 14 19 2-s2.0-60649100839 10.1016/j.ejim.2008.03.006
26. Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., Hildebrandt P., N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. Journal of the American Medical Association 2005 293 13 1609 1616 2-s2.0-15944419583 10.1001/jama.293.13.1609 (Pubitemid 40471791)
27. Beer S., Golay S., Bardy D., Feihl F., Gaillard R. C., Bachmann C., Waeber B., Ruiz J., Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications. Diabetes and Metabolism 2005 31 6 567 573 2-s2.0-29344472581 10.1016/S1262-3636(07)70232-X (Pubitemid 43001174)
28. Satoh N., Shimatsu A., Kato Y., Araki R., Koyama K., Okajima T., Tanabe M., Ooishi M., Kotani K., Ogawa Y., Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertension Research 2008 31 10 1921 1930 2-s2.0-58149394485 10.1291/hypres.31.1921
29. Holewijn S., den Heijer M., Swinkels D. W., Stalenhoef A. F. H., de Graaf J., The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis. Journal of Clinical Endocrinology and Metabolism 2009 94 8 2893 2899 2-s2.0-68549101574 10.1210/jc.2009-0084
30. Masugata H., Senda S., Okuyama H., Murao K., Inukai M., Hosomi N., Yukiiri K., Nishiyama A., Kohno M., Goda F., Comparison of central blood pressure and cardio-ankle vascular index for association with cardiac function in treated hypertensive patients. Hypertension Research 2009 32 12 1136 1142 2-s2.0-73849137759 10.1038/hr.2009.157
31. McEniery C. M., Yasmin, Maki-Petaja K. M., McDonnell B. J., Munnery M., Hickson S. S., Franklin S. S., Cockcroft J. R., Wilkinson I. B., The impact of cardiovascular risk factors on aortic stiffness and wave reflections depends on age: the Anglo-Cardiff Collaborative Trial (ACCT III). Hypertension 2010 56 4 591 597 2-s2.0-77957236665 10.1161/HYPERTENSIONAHA.110.156950
32. McEniery C. M., Yasmin, Hall I. R., Qasem A., Wilkinson I. B., Cockcroft J. R., Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). Journal of the American College of Cardiology 2005 46 9 1753 1760 2-s2.0-27444441183 10.1016/j.jacc.2005.07.037 (Pubitemid 41531635)
33. Kohara K., Tabara Y., Oshiumi A., Miyawaki Y., Kobayashi T., Miki T., Radial augmentation index: a useful and easily obtainable parameter for vascular aging. American Journal of Hypertension 2005 18 1, part 2 11S 14S 2-s2.0-15744390757 10.1016/j.amjhyper.2004.10.010 (Pubitemid 40416847)
34. Roman M. J., Okin P. M., Kizer J. R., Lee E. T., Howard B. V., Devereux R. B., Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study. Journal of Hypertension 2010 28 2 384 388 2-s2.0-75149150830 10.1097/HJH.0b013e328333d228
35. Heringlake M., Heide C., Bahlmann L., Eichler W., Pagel H., Schmucker P., Wergeland R., Armbruster F. P., Klaus S., Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers. Journal of Applied Physiology 2004 97 1 173 179 2-s2.0-3042657075 10.1152/japplphysiol.01196.2003 (Pubitemid 38802517)
36. Nejatizadeh A., Kumar R., Stobdan T., Goyal A. K., Gupta M., Javed S., Pasha M. A. Q., Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension. Journal of Hypertension 2008 26 6 1094 1101 2-s2.0-43449111513 10.1097/HJH.0b013e3282fad951 (Pubitemid 351670500)
37. Hitomi H., Kiyomoto H., Nishiyama A., Angiotensin II and oxidative stress. Current Opinion in Cardiology 2007 22 4 311 315 2-s2.0-34250172081 10.1097/HCO.0b013e3281532b53 (Pubitemid 46897282)